执行董事杨建新增持基石药业(02616)11.75万股 每股均价约5.42港元

Core Viewpoint - Executive Director Yang Jian has increased his stake in Basilea Pharmaceutica (02616) by acquiring 117,500 shares at an average price of HKD 5.4183 per share, totaling approximately HKD 636,700, which reflects confidence in the company's future prospects [1] Group 1 - The acquisition of shares brings Yang Jian's total holdings to approximately 71.4502 million shares, representing a holding percentage of 4.84% [1]